Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Journal of Proteome Research|August 9, 2005
Correcting common errors in identifying cancer-specific serum peptide signaturesJosep Villanueva, John Philip, Carlos A Chaparro, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 23, 2019
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacksJonathan A Bernstein, Huamin Henry Li, Timothy J Craig, et al.
Nanoscale Advances|November 1, 2024
Evidence of high electron mobility in magnetic kagome topological metal FeSn thin filmsLorenzo Mosesso, Luca Tomarchio, Niraj Bhattarai, et al.
The Canadian Journal of Cardiology|June 26, 2026
High Intensity Interval Training Versus Moderate Continuous Training in Adults with Congenital Heart Disease: A Randomized Controlled TrialRuochen Tony Mao, John Philip Willner, Stephen Pylypchuk, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 5, 2017
Betaglycan (TGFBR3) up-regulation correlates with increased TGF-β signaling in Marfan patient fibroblasts in vitroMenno Evert Groeneveld, Natalija Bogunovic, René John Philip Musters, et al.
Journal of Personality Assessment|January 27, 2025
Psychometric Properties of the Dutch Version of the Young Positive Schema Questionnaire (YPSQ-NL)Machteld A Ouwens, Loes Van Donzel, Daphne Schroevers, et al.
Journal of Clinical Pharmacology|September 6, 2025
A Phase 1 Randomized Study: Garadacimab Pharmacokinetics, Safety, and Tolerability After Administration via Autoinjector/Pre-Filled Pen Versus Pre-Filled Syringe in Healthy ParticipantsFiona Glassman, John-Philip Lawo, Mihai Alexandru Bica, et al.
Proteomics. Clinical Applications|March 5, 2014
Aminopeptidase activities as prospective urinary biomarkers for bladder cancerJennifer M Taylor, Mariana Yaneva, Kevin Velasco, et al.
International Journal of Hematology|March 19, 2021
Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational studyTomohiro Morio, Kenji Gotoh, Tomoyuki Imagawa, et al.
Journal of Clinical Immunology|November 12, 2018
Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 TrialsStephen Jolles, Mikhail A Rojavin, John-Philip Lawo, et al.
Pageof 19